Projects

CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES - Belgium 

Project overview (since 2010-01-01):

Start dateProjectacronymrolefundingpartners
2023-01-01Burden of disease based methods for estimating the socio-economic cost of environmental stressors BEST-COSTcoordinator3.997.71817
2023-01-01COMBATTING DIET RELATED NON-COMMUNICABLE DISEASE THROUGH ENHANCED SURVEILLANCE CoDietparticipant7.330.58917
2022-07-01FEAST FEASTparticipant11.724.64035
2022-07-01Next Generation Integrated Sensing and Analytical System for Monitoring and Assessing Radiofrequency Electromagnetic Field Exposure and Health NextGEMparticipant7.559.03920
2022-05-01Partnership for the Assessment of Risks from Chemicals PARCparticipant200.000.000199
2021-10-01Beyond COVID BY-COVIDparticipant12.000.00053
2021-10-01environmentAL Toxicity chEmical mixtuRes through aN innovative platform based on aged cardiac tissue model ALTERNATIVEparticipant5.499.75711
2021-09-01Innovations to accelerate vaccine development and manufacture Inno4Vacparticipant18.600.00041
2021-04-01RESpondIng to outbreaks through co-creaTIve sustainable inclusive equality stRatEgies RESISTIREparticipant5.214.28511
2021-04-01AN INNOVATIVE ANALYTICAL PLATFORM TO INVESTIGATE THE EFFECT AND TOXICITY OF MICRO AND NANO PLASTICS COMBINED WITH ENVIRONMENTAL CONTAMINANTS ON THE RISK OF ALLERGIC DISEASE IN PRECLINICAL AND CLINICAL Imptoxparticipant6.104.82312
2021-03-01HealthyCloud – Health Research & Innovation Cloud HealthyCloudparticipant2.999.97526
2021-01-01EGI Advanced Computing for EOSC EGI-ACEparticipant8.000.00046
2020-11-15Unravelling Data for Rapid Evidence-Based Response to COVID-19 unCoVerparticipant2.997.44030
2020-11-01Population Health Information Research Infrastructure PHIRIcoordinator4.980.32838
2020-06-01DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE TRANSVAC-DSparticipant1.879.21628
2020-02-01Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century IS_MIRRI21participant4.914.85621
2020-01-01NGS diagnostics in 21st century oncology: the best, for all, at all times oncNGScoordinator10.999.65918
2020-01-01EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS ERA4TBparticipant89.815.60033
2020-01-01RISK-BASED SCREENING FOR CERVICAL CANCER RISCCparticipant5.792.35511
2019-12-01METROFOOD-RI Preparatory Phase Project METROFOOD-PPparticipant3.999.89020
2019-06-01Giving Beekeeping Guidance by cOmputatiOnal-assisted Decision making B-GOODparticipant7.961.17017
2018-08-01Bringing a health claim to information: Measuring the impact of health data on the health outcomes of European citizens BAHCIcoordinator172.8001
2018-06-01Addressing the dual emerging threats of African Swine Fever and Lumpy Skin Disease in Europe (DEFEND) DEFENDparticipant5.600.00032
2018-01-01Promoting One Health in Europe through joint actions on foodborne zoonoses, antimicrobial resistance and emerging microbiological hazards. One Health EJPparticipant44.999.00046
2017-06-01European programme for the establishment of validated procedures for the detection and identification of biological toxins EuroBioToxparticipant7.998.74714
2017-06-01European programme for the establishment of validated procedures for the detection and identification of biological toxins EuroBioToxparticipant7.998.74714
2017-01-01Progressing towards the construction of METROFOOD-RI PRO-METROFOODparticipant1.959.53818
2017-01-01Progressing towards the construction of METROFOOD-RI PRO-METROFOODparticipant1.959.53818
2017-01-01European Human Biomonitoring Initiative HBM4EUparticipant49.933.77643
2017-01-01European Human Biomonitoring Initiative HBM4EUparticipant49.933.77643
2016-03-01Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924 VAC2VACparticipant7.850.00023
2016-03-01Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924 VAC2VACparticipant7.850.00023
2015-01-01TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development TBVAC2020participant18.200.00044
2013-11-01Development of an integrated approach based on validated and standardized methods to support the implementation of the EC recommendation for a definition of nanomaterial NANODEFINEparticipant6.999.28329
2013-11-01Comparing health services interventions for the prevention of HPV-related cancer COHEAHRparticipant5.991.52812
2013-03-01A common European approach to the regulatory testing of nanomaterials NANOREGparticipant10.000.00068
2012-01-01Establishment of Quality Assurances for the Detection of Biological Toxins of Potential Bioterrorism Risk EQuAToxparticipant1.338.6349
2012-01-01Rapid Field Diagnostics and Screening in Veterinary Medicine RAPIDIA-FIELDparticipant2.998.66912
2012-01-01Animal Health and Welfare ANIHWAparticipant1.999.91832
2012-01-01Training and Research AImed at Novel Antibacterial Solutions in Animals and People TRAIN-ASAPparticipant3.515.5879
2010-05-01health-economic modelling of PREvention strategies for Hpv-related Diseases in European CounTries PREHDICTparticipant2.963.53213
2010-03-01Identification and development of vaccine candidates for Buruli Ulcer Disease BuruliVacparticipant4.599.98316
2010-02-01"Development of Vaccines for bTV, EHDV and AHSV" ORBIVACparticipant2.999.72918
2010-01-01Discovery and preclinical development of new generation tuberculosis vaccines NEWTBVACparticipant11.996.73035